Consano Bio Gains FDA Fast Track for C-1101
BURLINGTON, Mass., August 18, 2026 Consano Bio, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted...
FDA Fast Track
Advertisement
Faeth Therapeutics Gains FDA Fast Track for PIKTOR
Austin, Texas — August 17, 2026 Faeth Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...
Skye Bioscience and Redx Pharma Plan $125M Merger
San Diego, California / Alderley Park, United Kingdom — August 14, 2026 Skye Bioscience, Inc. and Redx Pharma Limited...
Aurisco Advances Generic Oligonucleotide Manufacturing
Shanghai, China, August 14, 2026 Aurisco Pharmaceutical announced that its Yangzhou, China manufacturing facility has successfully completed a U.S....
Phanes Therapeutics Gains FDA Fast Track for Spevatamig
San Diego, California, August 14, 2026 Phanes Therapeutics, Inc., a clinical-stage biotechnology company focused on immuno-oncology drug discovery and...
Advertisements
Mereo BioPharma Advances Alvelestat Toward Phase 3 Trial
LONDON, UK; SOLANA BEACH, California; and AHMEDABAD, India, August 11, 2026 Mereo BioPharma Group plc and Sentynl Therapeutics, Inc.,...
Intelligent Bio Solutions Completes Clinical Study for FDA 510(k) Submission
NEW YORK, August 11, 2026 Intelligent Bio Solutions Inc. announced the completion of its multi-site Method Comparison Study for...
SNIPR Advances SNIPR001 With Compassionate-Use Clinical Evidence
COPENHAGEN, Denmark, August 12, 2026 SNIPR announced new clinical evidence supporting the translational potential of SNIPR001, its engineered CRISPR-enhanced...
Jazz to Acquire Actio Biosciences for Rare Epilepsy Drug
Dublin, Ireland & San Diego, California, USA, August 10, 2026 Jazz Pharmaceuticals plc and Actio Biosciences, Inc. have announced...
X4 Pharmaceuticals Reports Q2 2026 Results and Advances Mavorixafor Development
BOSTON, August 6, 2026 X4 Pharmaceuticals reported second quarter 2026 financial results while highlighting continued progress in the global...
Advertisement
